Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
STK11 mutation + FAT3 mutation
i
Other names:
FAT3, FAT Atypical Cadherin 3, CDHF15, Cadherin-Related Family Member 10, FAT Tumor Suppressor Homolog 3, Cadherin Family Member 15, Protocadherin Fat 3, KIAA1989, CDHR10, HFat3, FAT Tumor Suppressor Homolog 3 (Drosophila), Serine/Threonine-Protein Kinase 11, Liver Kinase B1, Serine/Threonine-Protein Kinase LKB1, Polarization-Related Protein LKB1, STK11, Serine/Threonine Kinase 11, Serine/Threonine-Protein Kinase STK11, Renal Carcinoma Antigen NY-REN-19
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
6794
;
120114
Related biomarkers:
Expression
Mutation
CNA
Others
‹
STK11 mutation (33)
KRAS mutation + STK11 mutation (8)
KRAS G12C + STK11 mutation (5)
STK11 mutation + KEAP1 mutation (5)
KRAS G12D + STK11 mutation (3)
KRAS mutation + STK11 mutation + KEAP1 mutation (2)
STK11 mutation + KEAP1 mutation + KRAS G12C (2)
STK11 mutation + TP53 mutation (2)
ATM S1905Ifs*25 + STK11 K262Sfs*25 (1)
EGFR wild-type + ALK wild-type + STK11 mutation (1)
KRAS G12V + STK11 mutation (1)
KRAS mutation + STK11 deletion + KEAP1 deletion (1)
KRAS mutation + STK11 mutation + TP53 mutation (1)
NFE2L2 mutation + STK11 mutation (1)
PTEN mutation + STK11 mutation (1)
STK11 D194E (1)
STK11 F354L (1)
STK11 K262Sfs*25 (1)
STK11 mutation + KEAP1 mutation + KRAS wild-type (1)
EGFR mutation + FAT3 mutation (1)
FAT3 mutation (1)
KEAP1 mutation + FAT3 mutation (1)
KEAP1 mutation + NFE2L2 mutation + STK11 mutation (0)
STK11 mutation (33)
KRAS mutation + STK11 mutation (8)
KRAS G12C + STK11 mutation (5)
STK11 mutation + KEAP1 mutation (5)
KRAS G12D + STK11 mutation (3)
KRAS mutation + STK11 mutation + KEAP1 mutation (2)
STK11 mutation + KEAP1 mutation + KRAS G12C (2)
STK11 mutation + TP53 mutation (2)
ATM S1905Ifs*25 + STK11 K262Sfs*25 (1)
EGFR wild-type + ALK wild-type + STK11 mutation (1)
KRAS G12V + STK11 mutation (1)
KRAS mutation + STK11 deletion + KEAP1 deletion (1)
KRAS mutation + STK11 mutation + TP53 mutation (1)
NFE2L2 mutation + STK11 mutation (1)
PTEN mutation + STK11 mutation (1)
STK11 D194E (1)
STK11 F354L (1)
STK11 K262Sfs*25 (1)
STK11 mutation + KEAP1 mutation + KRAS wild-type (1)
EGFR mutation + FAT3 mutation (1)
FAT3 mutation (1)
KEAP1 mutation + FAT3 mutation (1)
KEAP1 mutation + NFE2L2 mutation + STK11 mutation (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
STK11 mutation + FAT3 mutation
Non Small Cell Lung Cancer
STK11 mutation + FAT3 mutation
Non Small Cell Lung Cancer
atezolizumab
Sensitive: C3 – Early Trials
atezolizumab
Sensitive
:
C3
atezolizumab
Sensitive: C3 – Early Trials
atezolizumab
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.